Originally published in the Portland Business Journal 6/30/20
Active Path, which specializes in a noninvasive alternative treatment for drug-resistant depression, has raised $2 million, which it will use to fuel a regional expansion.
The private placement round was from 3×5 Partners, a life sciences and natural resources venture capital firm headquartered in Portland, according to the announcement. Active Recovery, which offers transcranial magnetic stimulation, plans expand across the Portland metro area, the Willamette Valley and beyond.
Read the entire article here.
